Meeting
2020 Gastrointestinal Cancers Symposium
Long-term outcome after combined carbon-ion radiotherapy and chemotherapy for locally advanced pancreatic cancer.
Authors
Makoto Shinoto
Ion Beam Therapy Center, SAGA HIMAT Foundation, Tosu, Japan
Makoto Shinoto , Hidenari Hirata , Hiroaki Suefuji , Shingo Toyama , Minoru Ueda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 671)
Abstract #
671
Poster Bd #
J2
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
A single institutional experience of carbon-ion radiotherapy for locally advanced pancreatic cancer.
First Author: Makoto Shinoto
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Lymphopenia and spleen dose for patients with inoperable pancreatic cancer receiving ablative 5-fraction radiation therapy.
First Author: Michael David Chuong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
KRAS mutation status in the prediction of pancreatic tumor response after neoadjuvant systemic therapy and magnetic resonance-guided SBRT.
First Author: Amit Jethanandani
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.